rs3106798

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000090.4(COL3A1):​c.1510-290C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 152,098 control chromosomes in the GnomAD database, including 11,614 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 11614 hom., cov: 32)

Consequence

COL3A1
NM_000090.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.806

Publications

2 publications found
Variant links:
Genes affected
COL3A1 (HGNC:2201): (collagen type III alpha 1 chain) This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]
MIR3606 (HGNC:38881): (microRNA 3606) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-188995402-C-T is Benign according to our data. Variant chr2-188995402-C-T is described in ClinVar as Benign. ClinVar VariationId is 670964.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.588 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000090.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL3A1
NM_000090.4
MANE Select
c.1510-290C>T
intron
N/ANP_000081.2P02461-1
MIR3606
NR_037401.1
n.-228C>T
upstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL3A1
ENST00000304636.9
TSL:1 MANE Select
c.1510-290C>T
intron
N/AENSP00000304408.4P02461-1
COL3A1
ENST00000450867.2
TSL:1
c.1411-290C>T
intron
N/AENSP00000415346.2H7C435
COL3A1
ENST00000879201.1
c.1501-290C>T
intron
N/AENSP00000549260.1

Frequencies

GnomAD3 genomes
AF:
0.356
AC:
54144
AN:
151980
Hom.:
11612
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.112
Gnomad AMI
AF:
0.435
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.606
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.558
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.429
Gnomad OTH
AF:
0.328
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.356
AC:
54153
AN:
152098
Hom.:
11614
Cov.:
32
AF XY:
0.365
AC XY:
27149
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.112
AC:
4656
AN:
41516
American (AMR)
AF:
0.448
AC:
6848
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
1071
AN:
3470
East Asian (EAS)
AF:
0.605
AC:
3125
AN:
5162
South Asian (SAS)
AF:
0.463
AC:
2233
AN:
4826
European-Finnish (FIN)
AF:
0.558
AC:
5891
AN:
10552
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.429
AC:
29161
AN:
67968
Other (OTH)
AF:
0.329
AC:
695
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1592
3185
4777
6370
7962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.402
Hom.:
4481
Bravo
AF:
0.338
Asia WGS
AF:
0.500
AC:
1739
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.28
DANN
Benign
0.67
PhyloP100
-0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3106798; hg19: chr2-189860128; API